A Guide to Primary Care of People with HIV/AIDS - Canadian Public ...
A Guide to Primary Care of People with HIV/AIDS - Canadian Public ...
A Guide to Primary Care of People with HIV/AIDS - Canadian Public ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
A <strong>Guide</strong> <strong>to</strong> <strong>Primary</strong> <strong>Care</strong> <strong>of</strong> <strong>People</strong> <strong>with</strong> <strong>HIV</strong>/<strong>AIDS</strong><br />
Chapter 17: Quality Improvement<br />
17<br />
Table 17-4. Examples <strong>of</strong> Specific Measures<br />
<strong>with</strong> Definitions <strong>of</strong> Responses<br />
Measure<br />
TB screening<br />
(Eligibility: <strong>HIV</strong>infected<br />
patients<br />
<strong>with</strong>out a his<strong>to</strong>ry<br />
<strong>of</strong> previous TB<br />
treatment or<br />
a his<strong>to</strong>ry <strong>of</strong> a<br />
positive PPD)<br />
PCP prophylaxis<br />
Definition <strong>of</strong><br />
measure<br />
Was PPD testing<br />
performed (placed<br />
and read <strong>with</strong>in<br />
72 hours) in the<br />
past 12 months?<br />
Did the patient<br />
<strong>with</strong> 200/<br />
mm 3 during the<br />
last 6 months <strong>of</strong><br />
the review period<br />
receive PCP<br />
prophylaxis?<br />
Yes/No<br />
response<br />
Yes: PPD screening<br />
was performed<br />
(placed and read)<br />
No: PPD<br />
screening was not<br />
performed (or it<br />
was placed but<br />
results were not<br />
documented)<br />
Yes: The patient<br />
received PCP<br />
prophylaxis<br />
No: The patient<br />
did not receive<br />
PCP prophylaxis<br />
The data collection plan includes determining the<br />
source <strong>of</strong> information, such as whether medical records<br />
or an electronic database will be used, how the data<br />
will be recorded, who will record the data, and how a<br />
sample will be selected. A representative sample will<br />
allow inferences <strong>to</strong> be made about the clinic population<br />
based on observations <strong>of</strong> the smaller sample. Some<br />
form <strong>of</strong> random sampling should be used, either from<br />
a random numbers table, or a selection <strong>of</strong> every nth<br />
record from the list <strong>of</strong> eligible patients.<br />
A common pitfall at this point is <strong>to</strong> think <strong>of</strong> the<br />
measurement sample as a research project. For the<br />
purposes <strong>of</strong> QI, a sample just needs <strong>to</strong> be current,<br />
representative, and readily obtained (ie, sample size<br />
calculations and the achievement <strong>of</strong> statistically<br />
significant results are not necessary).<br />
Should you measure only one indica<strong>to</strong>r at a time?<br />
Definitely not. Several indica<strong>to</strong>rs should be measured<br />
simultaneously, whether abstracted from medical<br />
records or analyzed through administrative databases.<br />
Indica<strong>to</strong>rs reflecting different aspects <strong>of</strong> patient<br />
management should be selected, as well as those<br />
involving different populations. Indica<strong>to</strong>rs should also<br />
be selected <strong>to</strong> evaluate different components <strong>of</strong> the<br />
health care system, such as the different components <strong>of</strong><br />
the chronic disease model.<br />
How should you analyze and display data?<br />
Data should be reviewed and distributed <strong>to</strong> all members<br />
<strong>of</strong> the team and others involved in the care process<br />
under evaluation. Whenever possible, data should be<br />
displayed in graphic format. Once data from several<br />
time periods have been collected (eg, rates <strong>of</strong> patients<br />
<strong>with</strong> viral load performed every 4 months collected<br />
in 2 different time periods), a simple line graph (run<br />
chart) can be constructed <strong>with</strong> each point representing<br />
a performance rate (percentage) for a given period <strong>of</strong><br />
time. This is usually the simplest and most effective<br />
way <strong>to</strong> show performance data (see Figure 17-1).<br />
Figure 17-1: Sample Run Chart: Percentage<br />
<strong>of</strong> Patients PPD Tested, by Month<br />
Run Chart: Annual PPD Rate<br />
100%<br />
90%<br />
80%<br />
70%<br />
60%<br />
50%<br />
40%<br />
30%<br />
20%<br />
10%<br />
0%<br />
Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec<br />
Source: Measuring Clinical Performace: A <strong>Guide</strong> for <strong>HIV</strong> Health <strong>Care</strong><br />
Providers. New York, NY: New York State Department <strong>of</strong> Health <strong>AIDS</strong><br />
Institute. April, 2002.<br />
How does improvement occur?<br />
Once the data have been reviewed by the team and the<br />
process for improvement identified, the next step is <strong>to</strong><br />
decide where opportunities for improvement exist. This<br />
process is described as the PDSA (Plan-Do-Study-Act) or<br />
PDCA (Plan-Do-Check-Act) cycle (see Figure 17-2).<br />
The first step is <strong>to</strong> investigate this care process in<br />
greater detail. Several techniques are <strong>of</strong>ten used <strong>to</strong><br />
accomplish this goal. The simplest is brains<strong>to</strong>rming,<br />
in which individuals <strong>of</strong>fer their suggestions for which<br />
processes are the best candidates for change. Another<br />
easy method is flowcharting, in which the group breaks<br />
down the process in<strong>to</strong> its components <strong>to</strong> identify how<br />
it is coordinated and how its parts fit <strong>to</strong>gether. Then,<br />
the areas that would be most likely <strong>to</strong> benefit from<br />
improvement are selected for change (see Figure 17-3).<br />
144<br />
U.S. Department <strong>of</strong> Health and Human Services, Health Resources and Services Administration, <strong>HIV</strong>/<strong>AIDS</strong> Bureau